DUPONT CAPITAL MANAGEMENT CORP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 33 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$1,412
-56.8%
20,0000.0%0.00%
Q4 2022$3,268
-18.3%
20,0000.0%0.00%
Q3 2022$4,000
+33.3%
20,0000.0%0.00%
Q2 2022$3,000
-57.1%
20,0000.0%0.00%
Q1 2022$7,000
-63.2%
20,0000.0%0.00%
-100.0%
Q4 2021$19,000
+5.6%
20,0000.0%0.00%0.0%
Q3 2021$18,00020,0000.00%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 60,000$584,0000.06%
Empery Asset Management, LP 39,700$6,0000.03%
Radcliffe Capital Management, L.P. 80,001$779,0000.02%
Anson Funds Management LP 15,000$146,0000.01%
Segantii Capital Management Ltd 30,000$292,0000.01%
Arena Capital Advisors, LLC- CA 111,314$17,0000.00%
683 Capital Management, LLC 239,800$36,0000.00%
Atalaya Capital Management LP 100,000$15,0000.00%
MMCAP International Inc. SPC 159,802$24,0000.00%
MARSHALL WACE, LLP 54,995$536,0000.00%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders